Evidence map›Paper›PMID 34124025›Full record

ArticleFrontiers in bioengineering and biotechnology2021

New Continuous Process for the Production of Lipopeptide Biosurfactants in Foam Overflowing Bioreactor.

Jean-Sébastien Guez, Antoine Vassaux, Christian Larroche, Philippe Jacques, François Coutte

Abstract read
In one paragraph

Article in Frontiers in bioengineering and biotechnology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Does regulation hold the key to optimizing lipopeptide production inFrontiers in bioengineering and biotechnology · 2024
    Review
  10. Review
  11. GroEL Secreted fromMicroorganisms · 2023
    Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jean-Sébastien GuezUniversité Clermont Auvergne, Clermont Auvergne INP, CNRS, Institut Pascal, Clermont-Ferrand, France.
Antoine VassauxUniversité de Lille, UMRt BioEcoAgro 1158-INRAE, équipe Métabolites Secondaires d'origine Microbienne, Institut Charles Viollette, Lille, France.
Christian LarrocheUniversité Clermont Auvergne, Clermont Auvergne INP, CNRS, Institut Pascal, Clermont-Ferrand, France.
Philippe JacquesUniversité de Liège, UMRt BioEcoAgro 1158-INRAE, équipe Métabolites Secondaires d'origine Microbienne, TERRA Teaching and Research Centre, MiPI, Gembloux Agro-Bio Tech, Gembloux, Belgium.
François CoutteUniversité de Lille, UMRt BioEcoAgro 1158-INRAE, équipe Métabolites Secondaires d'origine Microbienne, Institut Charles Viollette, Lille, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this work, an original culture process in bioreactor named overflowing continuous culture (O-CC) was developed to produce and recover continuously mycosubtilin, a lipopeptide antifungal biosurfactant of major interest. The lipopeptide production was first investigated in shake conical flasks in different culture media [ammonium citrate sucrose (ACS), Difco sporulation medium (DSM), and Landy], followed by a pH condition optimization using 3-(

Indexed as

Bacillus subtilisbiosurfactantcontinuous culturecontinuous product removalfoaming processlipopeptide antibioticmycosubtilinoverflowing culture

Identifiers

PMID34124025
PMCPMC8194703

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.